AFP and cholangiocarcinoma: A series of studies from a Japanese liver cancer research team showed that 19% of patients with intrahepatic CCA had a serum AFP level greater than 20 ng/mL, 10.3% had greater than 200 ng/mL, and only 6.3% had greater than 1000 ng/mL [30].